AYESHA SILMAN: Open Payments
NPI 1003127101 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 5 payments from 4 companies in 2025. Trend: 2023 $74 · 2024 $152 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $222 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| ABBVIE INC. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: COBENFY, ABILIFY ASIMTUFII, VRAYLAR, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
